• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 523
  • 114
  • 68
  • 53
  • 30
  • 24
  • 11
  • 9
  • 8
  • 7
  • 6
  • 5
  • 4
  • 3
  • 3
  • Tagged with
  • 1066
  • 1066
  • 255
  • 113
  • 91
  • 83
  • 79
  • 76
  • 71
  • 66
  • 65
  • 61
  • 57
  • 55
  • 52
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
581

Development of Novel Approach for In Situ Generation of Oxidative Stress using KillerRed in C. elegans

Fu, Donald Wai-Bong 22 November 2012 (has links)
Oxidative stress has been implied in a wide variety of diseases, such as cancer, myocardial infarction, and neurodegenerative diseases including Parkinson's diseases (PD). PD is characterized by the degeneration of dopaminergic (DA) neurons; genetic studies have identified gene mutations causal to PD. Accumulating studies hypothesize that these genes protect DA neurons against oxidative stress. However, lack of experimental tools to target oxidative stress in specific cells has prevented direct evaluation of the hypothesis. We established a novel method to use KillerRed (KR), a genetically-encoded protein that generates radicals upon light activation. We showed its efficacy in live animals by cell-specific ablation of neurons in C. elegans. We applied KR to degenerate DA neurons. By controlling the level of stress via activation light, the protective role of PD-gene, LRRK2, against oxidative stress was confirmed. Thus, we established a method to address the role of oxidative stress in a cell-specific manner.
582

Development of Novel Approach for In Situ Generation of Oxidative Stress using KillerRed in C. elegans

Fu, Donald Wai-Bong 22 November 2012 (has links)
Oxidative stress has been implied in a wide variety of diseases, such as cancer, myocardial infarction, and neurodegenerative diseases including Parkinson's diseases (PD). PD is characterized by the degeneration of dopaminergic (DA) neurons; genetic studies have identified gene mutations causal to PD. Accumulating studies hypothesize that these genes protect DA neurons against oxidative stress. However, lack of experimental tools to target oxidative stress in specific cells has prevented direct evaluation of the hypothesis. We established a novel method to use KillerRed (KR), a genetically-encoded protein that generates radicals upon light activation. We showed its efficacy in live animals by cell-specific ablation of neurons in C. elegans. We applied KR to degenerate DA neurons. By controlling the level of stress via activation light, the protective role of PD-gene, LRRK2, against oxidative stress was confirmed. Thus, we established a method to address the role of oxidative stress in a cell-specific manner.
583

Zebrafish as a Model for the Study of Parkinson’s Disease

Xi, Yanwei 09 May 2011 (has links)
Parkinson’s disease (PD) is a common neurodegenerative disorder that is characterized by the degeneration of dopaminergic (DA) neurons in the substantia nigra and motor deficits. Although the majority of PD cases are sporadic, several genetic defects in rare familial cases have been identified. Animal models of these genetic defects have been created and have provided unique insights into the molecular mechanisms of the pathogenesis of PD. However, the etiology of PD is still not well understood. Here, taking advantage of the unique features offered by zebrafish, I characterized the functions of PINK1 (PTEN-induced kinase 1) gene, which is associated with recessive familial PD, in the development and survival of DA neurons. In zebrafish, antisense morpholino knockdown of pink1 did not cause a large loss of DA neurons in the ventral diencephalon (vDC), but the patterning of these neurons and their projections were perturbed. The pink1 morphants also showed impaired response to touch stimuli and reduced swimming behaviour. Moreover, the pink1 knockdown caused a significant reduction in the number of mitochondria, as well as mitochondrial morphological defects such as smaller size or loss of cristae, thus affecting mitochondrial function. These results suggest that zebrafish pink1 plays conserved important roles in the development of DA neurons and in the mitochondrial morphology and function. To better follow DA neurons after injury or administration of toxins, I generated a transgenic zebrafish line, Tg(dat:EGFP), in which the green fluorescent protein (GFP) is expressed under the control of cis-regulatory elements of dopamine transporter (dat). In Tg(dat:EGFP) fish, all major groups of DA neurons are correctly labeled with GFP, especially the ones in the vDC, which are analogous to the ascending midbrain DA neurons in mammals. In addition, we observed that the DA neurons in the vDC could partially be replaced after severe laser cell ablation. This suggests that zebrafish may have the unique capacity of regenerating DA neurons after injury. Taken together, my studies suggested that zebrafish could be a useful alternative animal model for the study of the molecular mechanisms underlying PD and for the screening of potential therapeutic compounds for PD.
584

Dopaminergic contributions to distance estimation in Parkinson’s disease: A sensory-perceptual deficit?

Ehgoetz Martens, Kaylena 10 1900 (has links)
Recent research has found that perceptual deficits exist in Parkinson’s disease (PD), yet the link between perception and movement impairments is not well understood. Inaccurate estimation of distance has the potential to be an underlying cause of movement impairments. Alternatively, those with PD may not be able to perceive their own movements accurately. The main objective of this thesis was to evaluate (1) whether distance estimation is influenced by static perception compared to perception during movement in PD, (2) how visual motion processing contributes to distance estimation during movement, and (3) how dopaminergic medication contributes to these distance estimation deficits. Thirty-seven participants (19 individuals with PD, 18 age-matched healthy control participants (HC) estimated distance to a remembered target in a total of 48 trials, in 4 randomized blocks. Estimation conditions included: (i) no motion: participants pointed with a laser, (ii) motion: participants walked to the estimated position, (iii) visual motion (wheelchair): participants were pushed in a wheelchair while they gave their estimate, (iv) visual motion (VR): participants completed their distance estimate while seated and viewed themselves (as if they were walking) in VR. PD patients completed this protocol twice; once OFF and once ON dopaminergic medication. Participants were matched for age, distance acuity, Modified Mini Mental State Exam (3MS), spatial working memory and motor planning ability. In Study 1 (no motion vs. motion), individuals with PD and healthy control participants did not differ in judgment accuracy during the no motion condition. However, those with PD did have greater amounts of error compared to healthy control participants while estimating distance during the motion condition. Similarly, those with PD significantly underestimated the target position compared to healthy control participants during the motion condition only. Individuals with PD demonstrated greater variability overall. In Study 2, error did not differ between PD and HC groups during visual motion perception (wheelchair). Interestingly, the HC group tended to perform significantly worse than those with PD in the VR condition. Overall, across both studies there was no significant influence of dopaminergic medication in any of the conditions. Individuals with PD demonstrated distance estimation deficits only when required to move through their environment. In contrast to estimations made with movement, neither static estimation nor estimations made with visual motion revealed significant differences between the two groups. Thus perceptual estimation deficits appear to occur only during movement, which may be suggestive of an underlying sensory processing deficit which leads to a problem integrating vision and self-motion information.
585

Quantitative Conjugate Imaging of Iodine-123 and Technetium-99m Labeled Brain Agents in the Basal Ganglia

Jangha, Desiree Nicole 10 July 2006 (has links)
In the research reported in this dissertation, the concept of classic conjugate imaging, a non-tomographic nuclear medicine technique, is modified such that activity of a radiopharmaceutical distribution in the striata can be estimated. A mathematical model is developed that extended the application of classic conjugate imaging to estimation of two distinct and aligned activity distributions. Error analysis of the mathematical model is performed to characterize the accuracy of the model and to benchmark the limitations of the model. Phantom experiments are performed to demonstrate the practical application of the model and to evaluate its accuracy. A Monte Carlo simulation model of conjugate imaging of activity uptake in the striata of a primate is developed to evaluate the accuracy of the modified conjugate imaging technique as applied in the use of a dedicate conjugate imaging system. In addition, the simulation model is used to determine and characterize the shielding design of the small field of view gamma cameras comprising the dedicated conjugate imaging system. The application of scatter correction is investigated to address the downscatter of high-energy photon emissions into the photopeak window and the inclusion of scattered primary photons in the photopeak window. In this dissertation, it is shown that the modified conjugate imaging technique developed can be used to estimate accurately activity uptake in each of two distinct and aligned activity distributions. The accuracy of the technique is shown to be comparable to that of clinical quantitative SPECT. The modified conjugate imaging technique used with the dedicated conjugate imaging system may, therefore, be a viable quantitative nuclear medicine technique for activity estimation of radiopharmaceutical uptake in the striata of Parkinsonian and schizophrenic patients. The portability and low cost relative to SPECT systems make a dedicated conjugate imaging system advantageous for clinics with Parkinsonian and schizophrenic patients, who are unable to travel due to physical or mental limitation.
586

Neurodegeneration und Neuroprotektion bei der Parkinson-Krankheit: Untersuchungen von β-Carbolinen und dem Dopaminagonisten Lisurid in der dopaminergen mesencephalen Primärzellkultur des Mausstammes C57Bl/6

Rauh, Juliane 15 April 2008 (has links) (PDF)
β-Carboline sind heterozyklische Indolalkaloide, die ubiquitär in unserer Umwelt und Nahrung vorkommen, aber auch endogen aus Tryptophan gebildet werden können. Aufgrund der strukturellen Verwandtschaft bestimmter β-Carboline zu dem dopaminergen Neurotoxin MPP+ wird ein möglicher Beitrag zur Pathogenese der Parkinson-Krankheit diskutiert. MPP+ ist seit langem für seine selektive Toxizität gegenüber dopaminergen Neuronen und das Auslösen von Parkinsonsymptomen bekannt. Insbesondere 2,9-DiMe-BC wurde in erhöhter Konzentration in der lumbalen cerebrospinalen Flüssigkeit von Parkinsonpatienten detektiert, jedoch nicht in Kontrollprobanden. Eine Inhibierung von Komplex I der mitochondrialen Atmungskette und eine selektive Toxizität auf DA Neurone konnten nachgewiesen werden. Die genauen Mechanismen des Zelltodes bleiben jedoch ungeklärt. Im Rahmen dieser Arbeit wurden die Mechanismen des Zelltodes, ausgelöst durch 2,9-DiMe-BC, in dopaminergen Primärzellkulturen des Mesencephalons von C57Bl/6-Mäusen untersucht. Drei weitere BC 2-Me-BC, 9-Me-BC und 1,9-DiMe-BC standen für Untersuchungen zur Verfügung. In ersten Experimenten wies 9-Me-BC und 1,9-DiMe-BC keine Toxizität gegenüber DA Neuronen auf. Aufgrund der höheren Toxizität von 2,9-DiMe-BC verglichen mit 2-Me-BC wurden nachfolgende Experimente mit dem zweifach methylierten BC durchgeführt. Durch die Behandlung mit 2,9-DiMe-BC konnte ein höherer Verlust der DA Neurone gegenüber anderen neuralen Zellen festgestellt werden. Eine selektive Aufnahme über den Dopamintransporter und damit verbundene Schädigung der DA Neurone, wie bei MPP+, konnte nicht nachgewiesen werden. Für 2,9-DiMe-BC wurde eine LC50 der DA Neurone von 14,1 µM und für MPP+ von 4,4 µM bestimmt. 2,9-DiMe-BC verursachte in der Gesamtkultur eine erhöhte Entstehung von reaktiven Sauerstoffspezies und eine gesteigerte Laktatproduktion. In diesem Zusammenhang kann eine Hemmung von Komplex I der Atmungskette vermutet werden. Des Weiteren konnte eine Verringerung des mitochondrialen Membranpotentials und des ATP-Gehaltes gemessen werden. Eine Aktivierung des apoptotischen Zelltodes wurde mit einer erhöhten Aktivität von Caspase-3 nachgewiesen. Durch die Behandlung mit 2,9-DiMe-BC wurde in der Primärzellkultur jedoch auch in erhöhtem Maß Nekrose ausgelöst. Dabei wurde eine höhere Sensitivität von jüngeren Kulturen (8. DIV) gegenüber älteren (10. DIV) festgestellt. Genexpressionsanalysen konnten das Auslösen von oxidativem Stress und Apoptose durch 2,9-DiMe-BC bestätigen, da mehrere Gene dieser Prozesse hochreguliert wurden. Des Weiteren wurden Gene reguliert, die im Zusammenhang mit der Hitzeschock-Antwort, Entzündungsprozessen, DNA-Schädigung und Reparatur, Zellalterung und Proliferation stehen. Zusammenfassend lässt sich sagen, dass 2,9-DiMe-BC die Mitochondrienaktivität hemmt, sowohl nekrotische als auch apoptotische Prozesse in der dopaminergen mesencephalen Primärzellkultur auslöst und die Entstehung von oxidativem Stress eine zentrale Rolle spielt. Der zweite Teil dieser Arbeit beschäftigte sich mit der Untersuchung von unerwarteten neuroprotektiven Effekten von 9-Me-BC in der Primärzellkultur. Durch die Behandlung mit 9-Me-BC verringerte sich die LDH-Freisetzung und reduzierte sich die Anzahl der nekrotischen Zellen um 50 %. Nach 24 h konnte eine verminderte Caspase 3-Aktivität gemessen werden, die allerdings nach 48 h im Vergleich zur Kontrolle wieder zunahm. Hier wären längerfristige Untersuchungen zur Klärung dieser Frage anzuschließen. Des Weiteren erhöhte sich der intrazelluläre ATP-Gehalt. Möglicherweise fand eine energieabhängige Verschiebung von Nekrose zu Apoptose statt. Genexpressionsanalysen zeigten, dass verschiedene Gene von inflammatorischen und apoptotischen Signaltransduktionswegen herrunterreguliert wurden. Überraschenderweise erhöhte sich nach der Behandlung mit 9-Me-BC die Anzahl DA Neurone konzentrationsabhängig um bis zu 20 %. Diese Beobachtung ist neu und wurde über noch kein anderes BC berichtet. Der Effekt wurde durch die Inhibierung des DAT aufgehoben und lässt eine DAT-abhängige Aufnahme von 9-Me-BC vermuten. Die signifikante Erhöhung der Anzahl beschränkte sich nur auf DA Neurone, während sich der Gesamtanteil der Neurone nur geringfügig erhöhte und die übrigen Zellen unbeeinflusst blieben. Zusätzlich wurden ein erhöhter intrazellulärer DA-Gehalt und eine gesteigerte Aufnahme von [3H]DA um 20 % nachgewiesen. Die [3H]DA-Aufnahme und morphologische Untersuchungen zeigten funktionale und reife DA Neurone, es wurde aber auch die Theorie der Neuentstehung durch mögliche Differenzierungsprozesse untersucht. Interessanterweise wurde die Genexpression von einem breiten Spektrum neurotropher Faktoren (Shh, Wnt1, Wnt5a) und Transkriptionsfaktoren (En1, Nurr1, Pitx3), die für die Differenzierung und Entwicklung DA Neurone entscheidend sind, durch die Behandlung mit 9-Me-BC hochreguliert. Zusätzlich erhöhte sich die Expression der DA Markergene Aldh1a1, Dat und Th. Dabei war die Hochregulierung der Genexpression bei allen Faktoren bis auf Shh und Wnt1 von der Anwesenheit des BC abhängig. Ein weiterer Aspekt, der auf eine Differenzierung hindeuten könnte, war die verringerte Anzahl mitotischer BrdU-positiver Zellen. Das Erscheinen DA Neurone könnte also auf Differenzierung und Entwicklung von undifferenzierten Zellen oder Vorläuferzellen beruhen. Jedoch wäre auch eine Induktion der TH von vorher TH-negativen Zellen denkbar. Eine weitere Erklärung könnte das Vorherrschen eines dynamischen Gleichgewichts von Absterben und Neuentstehung DA Neurone innerhalb der Primärzellkultur sein und der Absterbeprozess durch protektive Effekte von 9-Me-BC unterbunden wurde. Zukünftige Experimente sollten zu einer weiteren Aufklärung, der diesem Phänomen zu Grunde liegendenen Mechanismen beitragen. Auch durch die Behandlung mit dem Harman 1,9-DiMe-BC erhöhte sich die Anzahl der DA Neurone konzentrationsabhängig, jedoch erwies sich im Vergleich zu 9-Me-BC nur eine Konzentration von 50 µM als signifikant. Innerhalb dieser Arbeit wurden auf Genexpressionsebene mit Hilfe von Microarrays und qRT-PCR mögliche neuroprotektive Effekte des Dopaminagonisten Lisurid im gleichen Zellkulturmodell untersucht. Lisurid gehört zur Substanzklasse der Ergotalkaloide und wird zur Behandlung der Parkinson-Krankheit eingesetzt. Bei Voruntersuchungen in der DA mesencephalen Primärzellkultur wies Lisurid eine protektive Wirkung für DA Neurone gegen Glutamattoxizität auf. Durch qRT-PCR konnten nur 50 % der ausgewählten Gene der Microarraydaten validiert werden. Nach 24 h Behandlung mit Lisurid wurde die Genexpression von dem Transportprotein Transthyretin (Ttr) hochreguliert, dessen erhöhte Biosynthese und Sekretion interessanterweise mit einer Verminderung der Aggregation des Amyloid-β-Proteins assoziiert wird. Die Genexpression der Aldoketoreduktase 1c20 (Ark1c20) wurde um 50 % herrunterreguliert. Die Bedeutung dieses Ergebnisses bedarf weiterer Abklärung, da eine gewebspezifische Expression bisher nur für die Leber gefunden wurde. Das Thyroidhormonrezeptorbindende Protein 3 (Thrap3), die Mitogen aktivierte Kinase Kinase Kinase 12 (Map3k12) und der G-Protein gekoppelte Rezeptor 27 (Gpr27) waren in ihrer Genexpression hochreguliert. Ein Einfluss von Lisurid auf Signaltransduktionswege konnte somit nachgewiesen werden. Des Weiteren wurde durch Lisurid die Expression der Transkriptionsfaktoren NeuroD1 und Tcf3 hochreguliert, die in Differenzierungsprozesse involviert sind. NeuroD1 gilt dabei als proneurales Gen und ist somit möglicherweise an Vorgängen der Neuroprotektion beteiligt. Keines der validierten differentiell exprimierten Gene des 24 h Experimentes war nach einem Behandlungszeitraum von 6 h reguliert. Die Änderungen der Genexpression nach Preinkubation mit Lisurid und anschließender Glutamatbehandlung und Behandlung mit Glutamat allein überschnitten sich weitestgehend. Demnach war vor allem die Glutamatbehandlung für die differentielle Genexpression verantwortlich. Eine zusätzliche Neusynthese von radikalfangenden Proteinen durch Preinkubation mit Lisurid konnte auf Genebene nicht gefunden werden. Es ist jedoch nicht auszuschließen, da eine Regulation auf post-transkriptioneller Ebene möglich ist.
587

Neuron to microglia communication; a study of CX3CL1 signaling implications in cognitive function, inflammation, and neurodegeneration

Morganti, Joshua M 01 January 2012 (has links)
As a consequence of aging, the brain is subject to chronic neuroinflammatory conditions. The resident immune cells of the brain, microglia, act similarly to peripheral macrophages to protect the brain from insults, infection, and physical trauma. However, without proper regulation of their respective host defense mechanisms, these actions can become neurotoxic. In the healthy brain neurons have several signaling systems that directly interact with microglia in order to maintain a calming influence upon their actions, one of particular interest is the chemokine CX3CL1. This chemokine is found predominantly on neurons, while its cognate receptor CX3CR1 is found exclusively on microglia. There has been a recent surge in literature as to the exact role CX3CL1 signaling plays various physiological and neuropathological animal models, with still no well-defined role. In an attempt to address the current discordance regarding the role of CX3CL1 signaling we have used three different models. The first examines how genetic ablation of CX3CR1 impacts hippocampal dependent cognitive function. Secondly, we examined the impact of chronic LPS-induced neuroinflammation affects CX3CL1 signaling and ultimately cognitive function. Lastly, we used an acute mouse model of Parkinson's disease induced by MPTP to examine the effects of specific subtypes of CX3CL1. Although three unique approaches were used to examine the anti-inflammatory properties of CX3CL1, parallels can be drawn from the separate studies as similar results were obtained. CX3CL1 signaling has significant anti-inflammatory actions within the brain and alterations that prevent this signaling to occur can result in impairments in cognitive function as well as exacerbation of neurodegenerative conditions.
588

Characterization of the 5'flanking region of mitochondrial uncoupling protein 4 (UCP 4) and its relationship with nuclear factor-kappa B(NF-KB) in MPP+ -induced toxicity

Ho, Wing-man, Jessica., 何詠雯. January 2011 (has links)
published_or_final_version / Medicine / Doctoral / Doctor of Philosophy
589

Age-dependent effects of mitochondrial function in skin fibroblasts and skeletal muscle derived from a Parkinsonian LRRK2 R1441G knockinmouse model

So, Hon-fai., 蘇漢暉. January 2013 (has links)
Parkinson's disease (PD) is an age-related neurodegenerative disease characterized by the selective loss of dopaminergic neurons in the substantia nigra of the brain. The pathogenesis and etiology of PD are unclear. Mitochondrial dysfunction occurs in PD, causing a decrease in complex I activity in postmortem brain, and exacerbating reactive oxygen species production and ATP deficiency contributing to neuronal cell death. Mutation of leucine-rich-repeat kinase 2 (LRRK2) gene is the most common genetic factor identified in both familial and sporadic PD cases. Several mutations in LRRK2 have been linked to PD, in which R1441G is the second commonest mutation after G2019S. LRRK2 protein is ubiquitously expressed in human body, in which a portion is localized to the mitochondria. Mutations of LRRK2 directly or indirectly cause mitochondria dysfunction. Dysfunction of mitochondrial respiratory complexes has been described in skin fibroblasts and skeletal muscle of PD patients. Therefore, these clinically accessible tissues are good for monitoring disease progression. The objectives of this study were to investigate how LRRK2 R1441G mutation affects normal mitochondrial function, and whether this specific LRRK2 mutation potentiates age-dependent deterioration of mitochondrial function. To achieve these aims, colonies of skin fibroblast carrying LRRK2 R1441G mutation or wild-type LRRK2 were derived from a novel LRRK2 R1441G knock-in (KI) mouse model and its wild-type (WT) littermates. Skeletal muscles were dissected from the hind legs of WT and KI mice. The effects of aging and LRRK2 R1441G mutation on mitochondrial function were investigated in vitro using these derived skin fibroblast cultures, and ex vivo using skeletal muscle obtained from young (3-month-old) and aged (18-month-old) WT and KI mice. Reduction-oxidation activities of mitochondrial complex I and complex II in skin fibroblasts and skeletal muscle were measured spectrophotometrically. Intracellular ATP levels in skin fibroblasts were determined by bioluminescent assay. Phase-contrast microscopy showed that aging and LRRK2 R1441G mutation did not affect cell morphology of the derived skin fibroblast cultures. Complex I activity determined in skin fibroblasts and skeletal muscle derived from KI and their WT littermates revealed that, aging caused a significant increase in complex I activity in WT but not KI skin fibroblasts. Conversely, a significant decrease in complex I activity was observed in both WT and KI skeletal muscle, demonstrating an aging effect ex vivo. LRRK2 R1441G mutation did not affect complex I activity in WT and KI skin fibroblasts and skeletal muscle. Moreover, complex II activity in these two tissues was neither affected by aging nor R1441G LRRK2 mutation. Intracellular ATP levels in the skin fibroblast cultures were also unaltered by aging and LRRK2 R1441G mutation. In conclusion, my current findings indicated a significant aging effect on mitochondrial complex I activity ex vivo, supporting the role of age-dependent deterioration of complex I activity in mitochondrial dysfunction of PD. LRRK2 R1441G mutation did not affect complex I and II activities in both skin fibroblasts and skeletal muscle. Also, this mutation did not potentiate the age-dependent deterioration of complex I activities as observed in skin fibroblasts and skeletal muscle of the LRRK2 R1441G knock-in mice. / published_or_final_version / Medicine / Master / Master of Philosophy
590

Characterization of Protein-Metabolite and Protein-Substrate Interactions of Disease Genes

McFedries, Amanda Kathryn 04 December 2014 (has links)
Discovery of protein-metabolite and protein-substrate interactions that can specifically regulate genes involved in human biology is an important pursuit, as the study of such interactions can expand our understanding of human physiology and reveal novel therapeutic targets. The identification and characterization of these interactions can be approached from different perspectives. Chemists often use bioactive small molecules, such as natural products or synthetic compounds, as probes to identify therapeutically relevant protein targets. Biochemists and biologists often begin with a specific protein and seek to identify the endogenous ligands that bind to it. These interests have led to the development of methodology that relies heavily on synthetic and analytical chemistry to identify interactions, an approach that is complemented by in vivo strategies for validating the biological consequences of specific interactions.

Page generated in 0.0436 seconds